Safety and Efficacy Evaluation of IM19 Cells

Clinical trial NCT03344705 · UNKNOWN

Trial details

NCT number: NCT03344705
Sponsor: Beijing Immunochina Medical Science & Technology Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Hematological Malignancies

Start date: 2017-08-21
Primary completion: 2020-10-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.